Benlysta, first drug to treat lupus in 5 decades

• April 26, 2024

Benlysta is the first drug approved by The Food and Drug Administration from the United States in more than 56 years to treat lupus disease, offering some hope to the painful symptoms of this autoimmune condition, the newspaper reported. The Times .

The medication is developed by Human Genome Sciences Inc, and it will cost around 30 thousand dollars a year within the United States and 23 thousand outside the country.

"It's a historic day. It really opens a door, "he said. Sandra Raymond, president of the Lupus Foundation of America (LFA in its acronym in English). Although he stressed that he does not consider it a miracle drug and that they expect other pharmaceutical brands to produce it to reduce its cost.

A autoimmune disease As it is lupus, causes the body's immune system can not recognize the difference between healthy substances and harmful, so it begins to attack the organs and tissues of who suffers. Women are 9 times more likely to develop the condition than men.

It is estimated that in Mexico there are around 1.5 million people diagnosed with lupus, according to information from the Lupus and Pregnancy Clinic of the Specialties Hospital La Raza del IMSS.